Lung Cancer Screening Market Size, Share & Industry Analysis, By Cancer Type (Non-small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer); By Diagnosis Type (Low Dose Spiral CT Scan, and Chest X-ray), By End-user (Hospitals & Clinics, and Diagnostic Centers), and Regional Forecast, 2026-2034

Last Updated: January 26, 2026 | Format: PDF | Report ID: FBI101174

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 9.61% from 2026-2034
Unit	Value (USD Billion)
Segmentation	By Cancer Type Non-small Cell Lung Cancer (NSCLC) Small Cell Lung Cancer
	By Diagnosis Type Low Dose Spiral CT Scan Chest X-ray
	By End User Hospitals & Clinics Diagnostic Centers
	By Geography North America (By Cancer Type, By Diagnosis Type, By End User, and By Country) U.S. Canada Europe (By Cancer Type, By Diagnosis Type, By End User, and By Country/Sub-region) U.K. Germany France Italy Spain Scandinavia Rest of Europe Asia Pacific (By Cancer Type, By Diagnosis Type, By End User, and By Country/Sub-region) Japan China India Australia Southeast Asia Rest of Asia Pacific Latin America (By Cancer Type, By Diagnosis Type, By End User, and By Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Cancer Type, By Diagnosis Type, By End User, and By Country/Sub-region) GCC South Africa Rest of Middle East & Africa